Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
XENE compared with CRNX: revenue, margins and what each company keeps, and the suppliers and customers both name
XENE
Xenon Pharmaceuticals Inc.
Change
Mkt cap
Revenue
Revenue
CRNX
Crinetics Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
XENE
Xenon Pharmaceuticals Inc.
vs
CRNX
Crinetics Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
XENE: latest quarter is a loss; flow not drawable. CRNX: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
XENE, solid
CRNX, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only XENE
2
NBIX
Neurocrine Biosciences
supplier
BHC
Bausch Health
supplier
Shared
0
No shared counterparties.
Only CRNX
3
—
SKK
unlisted
customer
—
Loyal
unlisted
customer
—
Sanwa Kagaku Kenkyusho
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
XENE
Xenon Pharmaceuticals Inc.
Change
37.61
▲
+0.54%
· post 37.01
Mkt cap
$3.6B
Revenue
$8M
Q1 FY25
Revenue
—
CRNX
Crinetics Pharmaceuticals, Inc.
Change
84.97
▲
+0.15%
· post 84.97
Closed
Nov 2 '26
Mkt cap
$509.7M
Revenue
$25M
Q2 FY26
Revenue
$8M
FY25
vs
Compare
Closed
Nov 2 '26
XENE
Xenon Pharmaceuticals Inc.
vs
CRNX
Crinetics Pharmaceuticals, Inc.
37.61
▲
+0.54%
post 37.01
Price
84.97
▲
+0.15%
post 84.97
$3.6B
Mkt cap
$509.7M
Q1 FY25
$8M
Revenue
$25M
Q2 FY26
—
Revenue
$8M
FY25
Change
Change
XENE
37.61
▲
+0.54%
vs
CRNX
84.97
▲
+0.15%
Closed
Nov 2 '26